Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Shuch

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
European Urology|May 27, 2014
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexityBrian Shuch, Ali Amin, Andrew J Armstrong, et al.
Cancer|July 29, 2008
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performanceBrian Shuch, Jeff C La Rochelle, Jon Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical managementBrian Shuch, Srinivas Vourganti, Christopher J Ricketts, et al.
Cancer Genetics|February 2, 2025
Clinical and genetic characteristics in two cases of Birt-Hogg-Dubé syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variantsMark G Evans, Logan W Thomas, Manando Nakasaki, et al.
Journal of Kidney Cancer and VHL|October 31, 2022
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHLAileen Arevalo, Neal Patel, Peter Muraki, et al.
The Journal of Urology|September 10, 2013
Adverse health outcomes associated with surgical management of the small renal massBrian Shuch, Janet M Hanley, Julie C Lai, et al.
Cancer|May 16, 2013
Overall survival advantage with partial nephrectomy: a bias of observational data?Brian Shuch, Janet Hanley, Julie Lai, et al.
BJU International|April 16, 2008
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigmBrian Shuch, Stephen B Riggs, Jeff C LaRochelle, et al.
Cancer|August 2, 2008
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survivalBrian Shuch, Jeff C La Rochelle, Tobias Klatte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
A prospective study of leukocyte telomere length and risk of renal cell carcinomaJonathan N Hofmann, Qing Lan, Richard Cawthon, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
European Urology|May 27, 2014
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexityBrian Shuch, Ali Amin, Andrew J Armstrong, et al.
Cancer|July 29, 2008
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performanceBrian Shuch, Jeff C La Rochelle, Jon Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical managementBrian Shuch, Srinivas Vourganti, Christopher J Ricketts, et al.
Cancer Genetics|February 2, 2025
Clinical and genetic characteristics in two cases of Birt-Hogg-Dubé syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variantsMark G Evans, Logan W Thomas, Manando Nakasaki, et al.
Journal of Kidney Cancer and VHL|October 31, 2022
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHLAileen Arevalo, Neal Patel, Peter Muraki, et al.
The Journal of Urology|September 10, 2013
Adverse health outcomes associated with surgical management of the small renal massBrian Shuch, Janet M Hanley, Julie C Lai, et al.
Cancer|May 16, 2013
Overall survival advantage with partial nephrectomy: a bias of observational data?Brian Shuch, Janet Hanley, Julie Lai, et al.
BJU International|April 16, 2008
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigmBrian Shuch, Stephen B Riggs, Jeff C LaRochelle, et al.
Cancer|August 2, 2008
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survivalBrian Shuch, Jeff C La Rochelle, Tobias Klatte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
A prospective study of leukocyte telomere length and risk of renal cell carcinomaJonathan N Hofmann, Qing Lan, Richard Cawthon, et al.
Pageof 18